Total Funding
20
67
Total FundingVenture - Series Unknown raised
Growth Score
-6 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
90902
2C Tech is developing a novel, breakthrough nanotechnology based medical device.
Jim Taylor: CEOPast Role: ZEISS Group, CEO
Ramgopal Rao: CEO
About the Company
2C Tech is leveraging unique expertise in nanoparticle technologies for the creation of innovative therapeutic approaches for the treatment of ophthalmic diseases and conditions. The Company’s immediate focus is on the development of a proprietary therapy for patients with retinal degenerative conditions, for whom no effective treatment is
currently available. While initially focused on Retinitis Pigmentosa (RP), the 2C Tech approach could also have positive benefits in certain forms of Macular Degeneration, Glaucoma and Diabetic Retinopathy, where patient populations are far greater.
